These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35720382)

  • 1. Evaluation of Host Protein Biomarkers by ELISA From Whole Lysed Peripheral Blood for Development of Diagnostic Tests for Active Tuberculosis.
    Garlant HN; Ellappan K; Hewitt M; Perumal P; Pekeleke S; Wand N; Southern J; Kumar SV; Belgode H; Abubakar I; Sinha S; Vasan S; Joseph NM; Kempsell KE
    Front Immunol; 2022; 13():854327. PubMed ID: 35720382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.
    Perumal P; Abdullatif MB; Garlant HN; Honeyborne I; Lipman M; McHugh TD; Southern J; Breen R; Santis G; Ellappan K; Kumar SV; Belgode H; Abubakar I; Sinha S; Vasan SS; Joseph N; Kempsell KE
    Front Immunol; 2020; 11():612564. PubMed ID: 33841389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood RNA signatures outperform CRP triage of tuberculosis lymphadenitis and pericarditis.
    Mann T; Minnies S; Gupta RK; Reeve BW; Nyawo G; Palmer Z; Naidoo C; Doubell A; Pecararo A; John TJ; Schubert P; Calderwood CJ; Chandran A; Theron G; Noursadeghi M
    medRxiv; 2024 Jul; ():. PubMed ID: 38946942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease.
    Mutavhatsindi H; van der Spuy GD; Malherbe ST; Sutherland JS; Geluk A; Mayanja-Kizza H; Crampin AC; Kassa D; Howe R; Mihret A; Sheehama JA; Nepolo E; Günther G; Dockrell HM; Corstjens PLAM; Stanley K; Walzl G; Chegou NN;
    Front Immunol; 2021; 12():607827. PubMed ID: 33717089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of host protein signatures as a triage test for active pulmonary TB.
    Koeppel L; Denkinger CM; Wyss R; Broger T; Chegou NN; Dunty JM; Scott K; Cáceres T; Dutoit E; Ugarte-Gil C; Nicol M; Gotuzzo E; Corstjens PLAM; Geluk A; Sutherland J; Sigal GB; Moreau E; Albertini A; Mantsoki A; Ongarello S; Walzl G; Fernandez Suarez M
    J Clin Microbiol; 2023 Oct; 61(10):e0026423. PubMed ID: 37724874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing Tuberculosis: What Do New Technologies Allow Us to (Not) Do?
    Abdulgader SM; Okunola AO; Ndlangalavu G; Reeve BWP; Allwood BW; Koegelenberg CFN; Warren RM; Theron G
    Respiration; 2022; 101(9):797-813. PubMed ID: 35760050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL1: A new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice.
    Koyuncu D; Niazi MKK; Tavolara T; Abeijon C; Ginese ML; Liao Y; Mark C; Specht A; Gower AC; Restrepo BI; Gatti DM; Kramnik I; Gurcan M; Yener B; Beamer G
    PLoS Pathog; 2021 Aug; 17(8):e1009773. PubMed ID: 34403447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host Blood RNA Transcript and Protein Signatures for Sputum-Independent Diagnostics of Tuberculosis in Adults.
    Sivakumaran D; Ritz C; Gjøen JE; Vaz M; Selvam S; Ottenhoff THM; Doherty TM; Jenum S; Grewal HMS
    Front Immunol; 2020; 11():626049. PubMed ID: 33613569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis.
    Roe JK; Thomas N; Gil E; Best K; Tsaliki E; Morris-Jones S; Stafford S; Simpson N; Witt KD; Chain B; Miller RF; Martineau A; Noursadeghi M
    JCI Insight; 2016 Oct; 1(16):e87238. PubMed ID: 27734027
    [No Abstract]   [Full Text] [Related]  

  • 11. Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB).
    Richardson TR; Smith B; Malherbe ST; Shaw JA; Noor F; MacDonald C; van der Spuy GD; Stanley K; Carstens A; Fisher TL; van Rensburg I; Flinn M; Snyders C; Johnson I; Fransman B; Dockrell H; Thwaites G; Thuong NTT; Schacht C; Mayanja-Kizza H; Nsereko M; Tjon Kon Fat EM; Corstjens PLAM; Geluk A; Ruhwald M; Penn-Nicholson A; Chegou NN; Sutherland J; Walzl G;
    BMC Infect Dis; 2023 Jul; 23(1):447. PubMed ID: 37400753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection.
    Yang BF; Zhai F; Yu S; An HJ; Cao ZH; Liu YH; Wang R; Cheng XX
    Curr Med Sci; 2022 Dec; 42(6):1201-1212. PubMed ID: 36462134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of GBP1 in innate immunity and potential as a tuberculosis biomarker.
    Shi T; Huang L; Zhou Y; Tian J
    Sci Rep; 2022 Jun; 12(1):11097. PubMed ID: 35773466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.
    Hu X; Wang J; Ju Y; Zhang X; Qimanguli W; Li C; Yue L; Tuohetaerbaike B; Li Y; Wen H; Zhang W; Chen C; Yang Y; Wang J; Chen F
    BMC Infect Dis; 2022 Aug; 22(1):707. PubMed ID: 36008772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of heat shock proteins for discriminating between latent tuberculosis infection and active tuberculosis: A preliminary report.
    Shekhawat SD; Purohit HJ; Taori GM; Daginawala HF; Kashyap RS
    J Infect Public Health; 2016; 9(2):143-52. PubMed ID: 26300163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
    Penn-Nicholson A; Hraha T; Thompson EG; Sterling D; Mbandi SK; Wall KM; Fisher M; Suliman S; Shankar S; Hanekom WA; Janjic N; Hatherill M; Kaufmann SHE; Sutherland J; Walzl G; De Groote MA; Ochsner U; Zak DE; Scriba TJ;
    PLoS Med; 2019 Apr; 16(4):e1002781. PubMed ID: 30990820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis.
    De Groote MA; Sterling DG; Hraha T; Russell TM; Green LS; Wall K; Kraemer S; Ostroff R; Janjic N; Ochsner UA
    J Clin Microbiol; 2017 Oct; 55(10):3057-3071. PubMed ID: 28794177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers.
    Schiff HF; Walker NF; Ugarte-Gil C; Tebruegge M; Manousopoulou A; Garbis SD; Mansour S; Wong PHM; Rockett G; Piazza P; Niranjan M; Vallejo AF; Woelk CH; Wilkinson RJ; Tezera LB; Garay-Baquero D; Elkington P
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38512356
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.